<?xml version="1.0" encoding="UTF-8"?>
<p> Importantly, new developments, including clinical data on BCG revaccination and the M72/AS01E TB vaccine candidate have been incorporated to reflect the major recent advances in the field. This review is a comprehensive and useful reference for the current state of TB vaccine development.</p>
